Neuroelectrics develops non-invasive neurotechnology systems that combine wireless EEG monitoring with brain stimulation. The company’s product portfolio includes devices such as Starstim and Enobio, which are designed to support both neural recording and stimulation within a single platform. Its systems are used across research, clinical trials, and therapeutic development contexts. Neuroelectrics positions its technology within regulated clinical and research environments rather than consumer wellness.

The technology integrates electroencephalography with transcranial electrical stimulation techniques to enable simultaneous measurement and modulation of brain activity. Wireless operation supports flexible experimental and clinical setups, while software tools allow configuration of stimulation protocols and real-time data analysis. This combined sensing-and-stimulation architecture supports closed-loop and adaptive neuromodulation paradigms. The platform emphasizes versatility across experimental, investigational, and therapeutic use cases.

Neuroelectrics targets neuroscience researchers, clinical trial sponsors, and healthcare providers developing or evaluating neuromodulation therapies. The systems are intended for use in structured research and clinical settings under professional supervision. Its focus reflects broader efforts to advance non-invasive brain stimulation through integrated, programmable, and data-driven neurotechnology platforms.